Özcan Met

Københavns Universitet

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (19)

Cansu Cimen Bozkus

Purdue University

UNITED STATES

View details

Lars Grøntved

University of Southern Denmark

DENMARK

View details

Nikolaj Pagh Kristensen

University Hospital Erlangen

GERMANY

View details

Nicolai Grønne Jørgensen

Københavns Universitet

DENMARK

View details

Ilia Kurochkin

Lund University

SWEDEN

View details

Andre Rosa

Lund University

SWEDEN

View details

Marion Humbert

Assistant Professor (Maître de conférences)

Université Grenoble Alpes

FRANCE

View details

Valesca Retèl

Erasmus University Rotterdam

NETHERLANDS

View details

Malin Lindstedt

Lund University

SWEDEN

View details

Mads Hald Andersen

Professor, dr.techn., Director

DENMARK

View details

Daniel Hargboel Madsen

Associate Professor

University of Copenhagen

DENMARK

View details

Thomas Stauffer Larsen

Odense University Hospital

DENMARK

View details

Eric Paul Bennett

Københavns Universitet

DENMARK

View details

Marco Donia

Copenhagen University Hospital

DENMARK

View details

Anne Gang

MD, PhD, Associated professor

Rigshospitalet

DENMARK

View details

stephanie hugues

Associate Professor

University of Geneva

SWITZERLAND

View details

Ervin Ascic

Lund University

SWEDEN

View details

Inge Marie Svane

Københavns Universitet

DENMARK

View details

Michal Bassani-Sternberg

University of Lausanne

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Özcan Met

Research Interests

Explore related searches

Contact this professor

Articles (19)

ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionality

Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells

In vivo dendritic cell reprogramming for cancer immunotherapy

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

Reduced mitochondrial respiration in peripheral T cells after paediatric heamatopoietic stem cell transplantation.

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma

202A cancer immunotherapy modality based on dendritic cell reprogramming in vivo

Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Restoring tumor immunogenicity with dendritic cell reprogramming

Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

Collaborators (19)

Cansu Cimen Bozkus

Lars Grøntved

Nikolaj Pagh Kristensen

Nicolai Grønne Jørgensen

Ilia Kurochkin

Andre Rosa

Marion Humbert

Valesca Retèl

Malin Lindstedt

Mads Hald Andersen

Daniel Hargboel Madsen

Thomas Stauffer Larsen

Eric Paul Bennett

Marco Donia

Anne Gang

stephanie hugues

Ervin Ascic

Inge Marie Svane

Michal Bassani-Sternberg

Make your next move.